Cart
sales@molnova.com
Home - Products - Angiogenesis - VEGFR - DMH4

DMH4

CAS No. 515880-75-8

DMH4( —— )

Catalog No. M33846 CAS No. 515880-75-8

DMH4 is a potent and selective inhibitor of VEGFR2 with an IC50 of 0.16 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 53 Get Quote
5MG 71 Get Quote
10MG 102 Get Quote
25MG 163 Get Quote
50MG 241 Get Quote
100MG 348 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    DMH4
  • Note
    Research use only, not for human use.
  • Brief Description
    DMH4 is a potent and selective inhibitor of VEGFR2 with an IC50 of 0.16 μM.
  • Description
    DMH4 is a potent and selective inhibitor of VEGFR2 with an IC50 of 0.16 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    VEGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    515880-75-8
  • Formula Weight
    400.47
  • Molecular Formula
    C24H24N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CN1CCOCC1)Oc1ccc(cc1)-c1cnc2c(cnn2c1)-c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hao J, et al. In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem Biol. 2010 Feb 19;5(2):245-53.??
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Lariciresinol

    Lariciresinol is an enterolignan precursor, it possesses fungicidal activities by disrupting the fungal plasma membrane and therapeutic potential as a novel antifungal agent for the treatment of fungal infectious diseases in humans. Dietary lariciresinol can attenuate mammary tumor growth and reduce blood vessel density in human MCF-7 breast cancer xenografts and carcinogen-induced mammary tumors in rats.

  • BMS-605541

    BMS-605541 is a potent and selective inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2) kinase activity(Ki=49 nM).

  • R1530

    R1530 is a multikinase inhibitor with antineoplastic and antiangiogenesis activities.

Sign In Join Free